Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 57.87% is in line with its 5-year average of 62.96%, around the middle of its 5-year range (20.39%–95.57%).
0.52% above its 12-month average of 57.57%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 67.61%.
GROSS MARGIN
57.87%
GROSS MARGIN AVG TTM
57.57%
GROSS MARGIN AVG 3Y
60.34%
GROSS MARGIN AVG 5Y
62.96%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.52%
CURRENT VS 3Y AVG
-4.09%
CURRENT VS 5Y AVG
-8.09%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.63%
median of 726 covered companies
CURRENT VS SECTOR MEDIAN
+42.43%
vs the sector median at left
Eton Pharmaceuticals, Inc.
Market Cap
$1.51B
Gross Margin
57.87%
TTM Avg
57.57%
3Y Avg
60.34%
5Y Avg
62.96%
Market Cap
$1.50B
Gross Margin
33.71%
TTM Avg
32.28%
3Y Avg
31.46%
5Y Avg
31.45%
Market Cap
$1.54B
Gross Margin
51.26%
TTM Avg
45.83%
3Y Avg
28.18%
5Y Avg
37.38%
Market Cap
$1.48B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eton Pharmaceuticals, Inc. (ETON) | $1.51B | 57.87% | 57.57% | 60.34% | 62.96% |
| Phibro Animal Health Corporation (PAHC)vs › | $1.50B | 33.71% | 32.28% | 31.46% | 31.45% |
| Nutex Health, Inc. (NUTX)vs › | $1.54B | 51.26% | 45.83% | 28.18% | 37.38% |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.48B | 0.00% | 0.00% | 0.00% | 0.00% |
| uniQure N.V. (QURE)vs › | $1.53B | 89.53% | 60.98% | 58.20% | 16.96% |
| GH Research PLC (GHRS)vs › | $1.48B | 0.00% | 0.00% | 0.00% | 0.00% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 73.09% | 81.06% | 86.06% | 90.71% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.47B | N/A | N/A | N/A | N/A |
| Certara, Inc. (CERT)vs › | $1.46B | 58.33% | 60.70% | 60.53% | 60.29% |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | 17.33% | 13.16% | 12.65% | 13.31% |
Gross Margin
57.9%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 67.61% |
| 2026-03-31 | 60.72% |
| 2025-12-31 | 61.56% |
| 2025-09-30 | 34.97% |
| 2025-06-30 | 63.00% |
| 2025-03-31 | 57.06% |
| 2024-12-31 | 55.60% |
| 2024-09-30 | 61.04% |
| 2024-06-30 | 62.00% |
| 2024-03-31 | 62.85% |
| 2023-12-31 | 49.64% |
| 2023-09-30 | 62.65% |
| 2023-06-30 | 80.70% |
| 2023-03-31 | 63.08% |
| 2022-12-31 | 74.84% |
| 2022-09-30 | 62.69% |
| 2022-06-30 | 62.69% |
| 2022-03-31 | 67.00% |
| 2021-12-31 | 95.40% |
| 2021-09-30 | 20.39% |
| 2021-06-30 | 95.57% |
| 2021-03-31 | 86.64% |
| 2020-12-31 | -270.37% |
| 2020-09-30 | 10.56% |
| 2020-06-30 | -40.00% |
| 2020-03-31 | -3.03% |
| 2019-12-31 | 1.31% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 100.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
